4//SEC Filing
Elefant Dov 4
Accession 0001104659-21-032853
CIK 0001279704other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:46 PM ET
Size
6.0 KB
Accession
0001104659-21-032853
Insider Transaction Report
Form 4
Elefant Dov
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2021-03-04+430,000→ 430,000 totalExercise: $1.74Exp: 2031-03-04→ Common Stock (430,000 underlying)
Footnotes (1)
- [F1]This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years form the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeother
Related Parties
1- filerCIK 0001326487
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:46 PM ET
- Size
- 6.0 KB